- Home
- FF vs PROK Comparison
FF vs PROK Comparison
Compare FF & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- PROK
- Stock Information
- Founded
- FF N/A
- PROK 2015
- Country
- FF United States
- PROK United States
- Employees
- FF N/A
- PROK N/A
- Industry
- FF Major Chemicals
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FF Industrials
- PROK Health Care
- Exchange
- FF Nasdaq
- PROK Nasdaq
- Market Cap
- FF 224.1M
- PROK 220.6M
- IPO Year
- FF N/A
- PROK N/A
- Fundamental
- Price
- FF $5.18
- PROK $1.69
- Analyst Decision
- FF Strong Buy
- PROK Buy
- Analyst Count
- FF 1
- PROK 5
- Target Price
- FF $0.80
- PROK $4.50
- AVG Volume (30 Days)
- FF 365.6K
- PROK 446.4K
- Earning Date
- FF 11-08-2024
- PROK 11-12-2024
- Dividend Yield
- FF 4.63%
- PROK N/A
- EPS Growth
- FF 24.25
- PROK N/A
- EPS
- FF 0.82
- PROK N/A
- Revenue
- FF $273,839,000.00
- PROK N/A
- Revenue This Year
- FF N/A
- PROK N/A
- Revenue Next Year
- FF N/A
- PROK N/A
- P/E Ratio
- FF $6.32
- PROK N/A
- Revenue Growth
- FF N/A
- PROK N/A
- 52 Week Low
- FF $4.15
- PROK $1.18
- 52 Week High
- FF $8.36
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- FF 35.96
- PROK 45.01
- Support Level
- FF $5.07
- PROK $1.50
- Resistance Level
- FF $5.28
- PROK $1.81
- Average True Range (ATR)
- FF 0.23
- PROK 0.20
- MACD
- FF -0.05
- PROK -0.02
- Stochastic Oscillator
- FF 37.43
- PROK 24.84
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.